Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Monica Trapp, BSN, RN, TCTCN
CONTACT
Lead
Children's Hospital Medical Center, Cincinnati
The purpose of this study is to see if a vitamin-like substance called quercetin is safe for people who have a rare condition called Dyskeratosis congenita (DC) or telomere biology disorders (TBD). This study is a single arm, open-label pilot study. There is no randomization. This study will enroll approximately 12 patients with DC/TBD who will be treated with quercetin for 24 weeks.
Age
2–any
Sex
ALL
Healthy volunteers
Not accepted